Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Alzhemier’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

There’s intriguing news today about a technology that could improve treatment in people with Alzheimer’s. It uses sound waves ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...

The researchers found the presence of CMV antibodies all over patients with Alzheimer's disease, including the intestines, ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

ApoE is a key genetic risk factor for certain forms of Alzheimer's disease, whose 3 variants (E2, E3, E4) influence the progression of the disease in different ways. People carrying the E4 allele have ...

Nearly 80% of caregiving for people with Alzheimer’s disease or dementia occurs in the home but most caregivers don’t realize ...